nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—HTR6—Alzheimer's disease	0.585	1	CbGaD
Dihydroergotamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0444	0.432	CbGbCtD
Dihydroergotamine—CYP3A4—Donepezil—Alzheimer's disease	0.0355	0.345	CbGbCtD
Dihydroergotamine—CYP3A4—Galantamine—Alzheimer's disease	0.0228	0.223	CbGbCtD
Dihydroergotamine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0053	0.101	CbGeAlD
Dihydroergotamine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00513	0.0981	CbGeAlD
Dihydroergotamine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00427	0.0818	CbGeAlD
Dihydroergotamine—HTR1B—blood vessel—Alzheimer's disease	0.00262	0.0502	CbGeAlD
Dihydroergotamine—HTR1D—blood vessel—Alzheimer's disease	0.00254	0.0486	CbGeAlD
Dihydroergotamine—HTR6—forebrain—Alzheimer's disease	0.00229	0.0439	CbGeAlD
Dihydroergotamine—HTR6—telencephalon—Alzheimer's disease	0.00211	0.0404	CbGeAlD
Dihydroergotamine—Bromocriptine—HTR6—Alzheimer's disease	0.00154	0.625	CrCbGaD
Dihydroergotamine—HTR1B—forebrain—Alzheimer's disease	0.00138	0.0265	CbGeAlD
Dihydroergotamine—HTR1D—forebrain—Alzheimer's disease	0.00134	0.0256	CbGeAlD
Dihydroergotamine—HTR1B—telencephalon—Alzheimer's disease	0.00127	0.0243	CbGeAlD
Dihydroergotamine—HTR6—nervous system—Alzheimer's disease	0.00125	0.0238	CbGeAlD
Dihydroergotamine—HTR2B—forebrain—Alzheimer's disease	0.00125	0.0238	CbGeAlD
Dihydroergotamine—HTR1D—telencephalon—Alzheimer's disease	0.00123	0.0236	CbGeAlD
Dihydroergotamine—HTR6—central nervous system—Alzheimer's disease	0.0012	0.023	CbGeAlD
Dihydroergotamine—HTR2B—telencephalon—Alzheimer's disease	0.00115	0.0219	CbGeAlD
Dihydroergotamine—HTR1A—forebrain—Alzheimer's disease	0.00112	0.0214	CbGeAlD
Dihydroergotamine—HTR1A—telencephalon—Alzheimer's disease	0.00103	0.0196	CbGeAlD
Dihydroergotamine—HTR6—brain—Alzheimer's disease	0.000952	0.0182	CbGeAlD
Dihydroergotamine—ABCB1—blood vessel—Alzheimer's disease	0.000826	0.0158	CbGeAlD
Dihydroergotamine—ADRA2A—forebrain—Alzheimer's disease	0.000782	0.015	CbGeAlD
Dihydroergotamine—HTR1B—nervous system—Alzheimer's disease	0.000751	0.0144	CbGeAlD
Dihydroergotamine—HTR1D—nervous system—Alzheimer's disease	0.000727	0.0139	CbGeAlD
Dihydroergotamine—HTR1B—central nervous system—Alzheimer's disease	0.000723	0.0138	CbGeAlD
Dihydroergotamine—ADRA2A—telencephalon—Alzheimer's disease	0.000719	0.0138	CbGeAlD
Dihydroergotamine—HTR1D—central nervous system—Alzheimer's disease	0.0007	0.0134	CbGeAlD
Dihydroergotamine—HTR2B—nervous system—Alzheimer's disease	0.000676	0.0129	CbGeAlD
Dihydroergotamine—Eye pain—Rivastigmine—Alzheimer's disease	0.00067	0.00337	CcSEcCtD
Dihydroergotamine—Hot flush—Memantine—Alzheimer's disease	0.000661	0.00332	CcSEcCtD
Dihydroergotamine—Injury—Rivastigmine—Alzheimer's disease	0.000659	0.00331	CcSEcCtD
Dihydroergotamine—Face oedema—Donepezil—Alzheimer's disease	0.000658	0.00331	CcSEcCtD
Dihydroergotamine—Menopausal symptoms—Memantine—Alzheimer's disease	0.000656	0.0033	CcSEcCtD
Dihydroergotamine—HTR2B—central nervous system—Alzheimer's disease	0.000651	0.0125	CbGeAlD
Dihydroergotamine—Hot flush—Rivastigmine—Alzheimer's disease	0.000647	0.00325	CcSEcCtD
Dihydroergotamine—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.000641	0.00322	CcSEcCtD
Dihydroergotamine—Epistaxis—Galantamine—Alzheimer's disease	0.000639	0.00321	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000631	0.00317	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000618	0.0031	CcSEcCtD
Dihydroergotamine—Cramp muscle—Donepezil—Alzheimer's disease	0.000614	0.00308	CcSEcCtD
Dihydroergotamine—Rhinitis—Galantamine—Alzheimer's disease	0.00061	0.00307	CcSEcCtD
Dihydroergotamine—HTR1A—nervous system—Alzheimer's disease	0.000606	0.0116	CbGeAlD
Dihydroergotamine—Muscular weakness—Donepezil—Alzheimer's disease	0.000601	0.00302	CcSEcCtD
Dihydroergotamine—Migraine—Rivastigmine—Alzheimer's disease	0.000596	0.00299	CcSEcCtD
Dihydroergotamine—Dysphagia—Donepezil—Alzheimer's disease	0.000589	0.00296	CcSEcCtD
Dihydroergotamine—Visual impairment—Galantamine—Alzheimer's disease	0.000586	0.00295	CcSEcCtD
Dihydroergotamine—Face oedema—Rivastigmine—Alzheimer's disease	0.000584	0.00294	CcSEcCtD
Dihydroergotamine—HTR1A—central nervous system—Alzheimer's disease	0.000583	0.0112	CbGeAlD
Dihydroergotamine—HTR1B—brain—Alzheimer's disease	0.000574	0.011	CbGeAlD
Dihydroergotamine—Angina pectoris—Donepezil—Alzheimer's disease	0.000574	0.00288	CcSEcCtD
Dihydroergotamine—Sweating increased—Donepezil—Alzheimer's disease	0.000574	0.00288	CcSEcCtD
Dihydroergotamine—HTR1A—cerebellum—Alzheimer's disease	0.00057	0.0109	CbGeAlD
Dihydroergotamine—Tinnitus—Galantamine—Alzheimer's disease	0.000567	0.00285	CcSEcCtD
Dihydroergotamine—Bronchitis—Donepezil—Alzheimer's disease	0.000566	0.00285	CcSEcCtD
Dihydroergotamine—Flushing—Galantamine—Alzheimer's disease	0.000565	0.00284	CcSEcCtD
Dihydroergotamine—HTR1D—brain—Alzheimer's disease	0.000556	0.0106	CbGeAlD
Dihydroergotamine—Muscular weakness—Memantine—Alzheimer's disease	0.000546	0.00274	CcSEcCtD
Dihydroergotamine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000545	0.00274	CcSEcCtD
Dihydroergotamine—Pollakiuria—Donepezil—Alzheimer's disease	0.000544	0.00273	CcSEcCtD
Dihydroergotamine—Dysphagia—Memantine—Alzheimer's disease	0.000535	0.00269	CcSEcCtD
Dihydroergotamine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000534	0.00268	CcSEcCtD
Dihydroergotamine—Bronchospasm—Memantine—Alzheimer's disease	0.000526	0.00264	CcSEcCtD
Dihydroergotamine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000523	0.00263	CcSEcCtD
Dihydroergotamine—Angina pectoris—Memantine—Alzheimer's disease	0.000521	0.00262	CcSEcCtD
Dihydroergotamine—Sweating increased—Memantine—Alzheimer's disease	0.000521	0.00262	CcSEcCtD
Dihydroergotamine—Tension—Galantamine—Alzheimer's disease	0.00052	0.00261	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000518	0.0026	CcSEcCtD
Dihydroergotamine—HTR2B—brain—Alzheimer's disease	0.000517	0.00989	CbGeAlD
Dihydroergotamine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000515	0.00259	CcSEcCtD
Dihydroergotamine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000515	0.00259	CcSEcCtD
Dihydroergotamine—Nervousness—Galantamine—Alzheimer's disease	0.000514	0.00259	CcSEcCtD
Dihydroergotamine—Bronchitis—Memantine—Alzheimer's disease	0.000514	0.00259	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Donepezil—Alzheimer's disease	0.00051	0.00257	CcSEcCtD
Dihydroergotamine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00051	0.00256	CcSEcCtD
Dihydroergotamine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00051	0.00256	CcSEcCtD
Dihydroergotamine—Muscle spasms—Galantamine—Alzheimer's disease	0.000509	0.00256	CcSEcCtD
Dihydroergotamine—Bronchitis—Rivastigmine—Alzheimer's disease	0.000503	0.00253	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000497	0.0025	CcSEcCtD
Dihydroergotamine—Tremor—Galantamine—Alzheimer's disease	0.000496	0.00249	CcSEcCtD
Dihydroergotamine—Epistaxis—Donepezil—Alzheimer's disease	0.000495	0.00249	CcSEcCtD
Dihydroergotamine—Pollakiuria—Memantine—Alzheimer's disease	0.000494	0.00248	CcSEcCtD
Dihydroergotamine—ABCB1—embryo—Alzheimer's disease	0.000493	0.00943	CbGeAlD
Dihydroergotamine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000491	0.00247	CcSEcCtD
Dihydroergotamine—Agitation—Galantamine—Alzheimer's disease	0.000487	0.00245	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000486	0.00244	CcSEcCtD
Dihydroergotamine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000483	0.00243	CcSEcCtD
Dihydroergotamine—Malaise—Galantamine—Alzheimer's disease	0.000478	0.0024	CcSEcCtD
Dihydroergotamine—Vertigo—Galantamine—Alzheimer's disease	0.000476	0.00239	CcSEcCtD
Dihydroergotamine—Rhinitis—Donepezil—Alzheimer's disease	0.000473	0.00238	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00047	0.00236	CcSEcCtD
Dihydroergotamine—Ergotamine—HTR2A—Alzheimer's disease	0.00047	0.191	CrCbGaD
Dihydroergotamine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000469	0.00236	CcSEcCtD
Dihydroergotamine—Palpitations—Galantamine—Alzheimer's disease	0.000468	0.00235	CcSEcCtD
Dihydroergotamine—Pharyngitis—Donepezil—Alzheimer's disease	0.000468	0.00235	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Memantine—Alzheimer's disease	0.000467	0.00235	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Memantine—Alzheimer's disease	0.000463	0.00233	CcSEcCtD
Dihydroergotamine—HTR1A—brain—Alzheimer's disease	0.000463	0.00886	CbGeAlD
Dihydroergotamine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00046	0.00231	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000457	0.0023	CcSEcCtD
Dihydroergotamine—Hypertension—Galantamine—Alzheimer's disease	0.000457	0.0023	CcSEcCtD
Dihydroergotamine—Visual impairment—Donepezil—Alzheimer's disease	0.000454	0.00228	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000453	0.00228	CcSEcCtD
Dihydroergotamine—Bromocriptine—HTR2A—Alzheimer's disease	0.000453	0.184	CrCbGaD
Dihydroergotamine—Arthralgia—Galantamine—Alzheimer's disease	0.000451	0.00227	CcSEcCtD
Dihydroergotamine—Myalgia—Galantamine—Alzheimer's disease	0.000451	0.00227	CcSEcCtD
Dihydroergotamine—Epistaxis—Memantine—Alzheimer's disease	0.00045	0.00226	CcSEcCtD
Dihydroergotamine—Anxiety—Galantamine—Alzheimer's disease	0.000449	0.00226	CcSEcCtD
Dihydroergotamine—Sinusitis—Memantine—Alzheimer's disease	0.000447	0.00225	CcSEcCtD
Dihydroergotamine—Discomfort—Galantamine—Alzheimer's disease	0.000445	0.00224	CcSEcCtD
Dihydroergotamine—Dry mouth—Galantamine—Alzheimer's disease	0.000441	0.00222	CcSEcCtD
Dihydroergotamine—Epistaxis—Rivastigmine—Alzheimer's disease	0.00044	0.00221	CcSEcCtD
Dihydroergotamine—Tinnitus—Donepezil—Alzheimer's disease	0.00044	0.00221	CcSEcCtD
Dihydroergotamine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000438	0.0022	CcSEcCtD
Dihydroergotamine—ABCB1—forebrain—Alzheimer's disease	0.000436	0.00834	CbGeAlD
Dihydroergotamine—Confusional state—Galantamine—Alzheimer's disease	0.000436	0.00219	CcSEcCtD
Dihydroergotamine—Rhinitis—Memantine—Alzheimer's disease	0.000429	0.00216	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000426	0.00214	CcSEcCtD
Dihydroergotamine—Shock—Galantamine—Alzheimer's disease	0.000425	0.00214	CcSEcCtD
Dihydroergotamine—Pharyngitis—Memantine—Alzheimer's disease	0.000425	0.00214	CcSEcCtD
Dihydroergotamine—ADRA2A—nervous system—Alzheimer's disease	0.000425	0.00813	CbGeAlD
Dihydroergotamine—Chills—Donepezil—Alzheimer's disease	0.000423	0.00213	CcSEcCtD
Dihydroergotamine—Tachycardia—Galantamine—Alzheimer's disease	0.000422	0.00212	CcSEcCtD
Dihydroergotamine—Rhinitis—Rivastigmine—Alzheimer's disease	0.00042	0.00211	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000418	0.0021	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000417	0.00209	CcSEcCtD
Dihydroergotamine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000416	0.00209	CcSEcCtD
Dihydroergotamine—Visual impairment—Memantine—Alzheimer's disease	0.000412	0.00207	CcSEcCtD
Dihydroergotamine—Anorexia—Galantamine—Alzheimer's disease	0.000412	0.00207	CcSEcCtD
Dihydroergotamine—ADRA2A—central nervous system—Alzheimer's disease	0.000409	0.00782	CbGeAlD
Dihydroergotamine—Hypotension—Galantamine—Alzheimer's disease	0.000404	0.00203	CcSEcCtD
Dihydroergotamine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000404	0.00203	CcSEcCtD
Dihydroergotamine—Tension—Donepezil—Alzheimer's disease	0.000403	0.00202	CcSEcCtD
Dihydroergotamine—ABCB1—telencephalon—Alzheimer's disease	0.000401	0.00767	CbGeAlD
Dihydroergotamine—ADRA2A—cerebellum—Alzheimer's disease	0.0004	0.00765	CbGeAlD
Dihydroergotamine—Tinnitus—Memantine—Alzheimer's disease	0.000399	0.00201	CcSEcCtD
Dihydroergotamine—Nervousness—Donepezil—Alzheimer's disease	0.000399	0.002	CcSEcCtD
Dihydroergotamine—Flushing—Memantine—Alzheimer's disease	0.000397	0.002	CcSEcCtD
Dihydroergotamine—Muscle spasms—Donepezil—Alzheimer's disease	0.000395	0.00198	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000394	0.00198	CcSEcCtD
Dihydroergotamine—Insomnia—Galantamine—Alzheimer's disease	0.000391	0.00196	CcSEcCtD
Dihydroergotamine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00039	0.00196	CcSEcCtD
Dihydroergotamine—Flushing—Rivastigmine—Alzheimer's disease	0.000389	0.00195	CcSEcCtD
Dihydroergotamine—Paraesthesia—Galantamine—Alzheimer's disease	0.000388	0.00195	CcSEcCtD
Dihydroergotamine—Tremor—Donepezil—Alzheimer's disease	0.000384	0.00193	CcSEcCtD
Dihydroergotamine—Somnolence—Galantamine—Alzheimer's disease	0.000384	0.00193	CcSEcCtD
Dihydroergotamine—Chills—Memantine—Alzheimer's disease	0.000384	0.00193	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000381	0.00191	CcSEcCtD
Dihydroergotamine—Dyspepsia—Galantamine—Alzheimer's disease	0.00038	0.00191	CcSEcCtD
Dihydroergotamine—Agitation—Donepezil—Alzheimer's disease	0.000377	0.0019	CcSEcCtD
Dihydroergotamine—Chills—Rivastigmine—Alzheimer's disease	0.000376	0.00189	CcSEcCtD
Dihydroergotamine—Decreased appetite—Galantamine—Alzheimer's disease	0.000376	0.00189	CcSEcCtD
Dihydroergotamine—Fatigue—Galantamine—Alzheimer's disease	0.000373	0.00187	CcSEcCtD
Dihydroergotamine—Malaise—Donepezil—Alzheimer's disease	0.00037	0.00186	CcSEcCtD
Dihydroergotamine—Vertigo—Donepezil—Alzheimer's disease	0.000369	0.00185	CcSEcCtD
Dihydroergotamine—Tension—Memantine—Alzheimer's disease	0.000366	0.00184	CcSEcCtD
Dihydroergotamine—Nervousness—Memantine—Alzheimer's disease	0.000362	0.00182	CcSEcCtD
Dihydroergotamine—Tension—Rivastigmine—Alzheimer's disease	0.000358	0.0018	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000356	0.00179	CcSEcCtD
Dihydroergotamine—Hypertension—Donepezil—Alzheimer's disease	0.000354	0.00178	CcSEcCtD
Dihydroergotamine—Nervousness—Rivastigmine—Alzheimer's disease	0.000354	0.00178	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000353	0.00178	CcSEcCtD
Dihydroergotamine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00035	0.00176	CcSEcCtD
Dihydroergotamine—Myalgia—Donepezil—Alzheimer's disease	0.000349	0.00176	CcSEcCtD
Dihydroergotamine—Arthralgia—Donepezil—Alzheimer's disease	0.000349	0.00176	CcSEcCtD
Dihydroergotamine—Tremor—Memantine—Alzheimer's disease	0.000349	0.00175	CcSEcCtD
Dihydroergotamine—Anxiety—Donepezil—Alzheimer's disease	0.000348	0.00175	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000346	0.00174	CcSEcCtD
Dihydroergotamine—Discomfort—Donepezil—Alzheimer's disease	0.000345	0.00174	CcSEcCtD
Dihydroergotamine—Agitation—Memantine—Alzheimer's disease	0.000342	0.00172	CcSEcCtD
Dihydroergotamine—Dry mouth—Donepezil—Alzheimer's disease	0.000342	0.00172	CcSEcCtD
Dihydroergotamine—Body temperature increased—Galantamine—Alzheimer's disease	0.000342	0.00172	CcSEcCtD
Dihydroergotamine—Abdominal pain—Galantamine—Alzheimer's disease	0.000342	0.00172	CcSEcCtD
Dihydroergotamine—Tremor—Rivastigmine—Alzheimer's disease	0.000342	0.00172	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000338	0.0017	CcSEcCtD
Dihydroergotamine—Confusional state—Donepezil—Alzheimer's disease	0.000338	0.0017	CcSEcCtD
Dihydroergotamine—Malaise—Memantine—Alzheimer's disease	0.000336	0.00169	CcSEcCtD
Dihydroergotamine—Agitation—Rivastigmine—Alzheimer's disease	0.000335	0.00168	CcSEcCtD
Dihydroergotamine—Oedema—Donepezil—Alzheimer's disease	0.000335	0.00168	CcSEcCtD
Dihydroergotamine—Vertigo—Memantine—Alzheimer's disease	0.000335	0.00168	CcSEcCtD
Dihydroergotamine—CYP3A4—nervous system—Alzheimer's disease	0.000334	0.0064	CbGeAlD
Dihydroergotamine—Shock—Donepezil—Alzheimer's disease	0.00033	0.00166	CcSEcCtD
Dihydroergotamine—Palpitations—Memantine—Alzheimer's disease	0.000329	0.00166	CcSEcCtD
Dihydroergotamine—Malaise—Rivastigmine—Alzheimer's disease	0.000329	0.00165	CcSEcCtD
Dihydroergotamine—Vertigo—Rivastigmine—Alzheimer's disease	0.000327	0.00165	CcSEcCtD
Dihydroergotamine—ADRA2A—brain—Alzheimer's disease	0.000325	0.00621	CbGeAlD
Dihydroergotamine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000324	0.00163	CcSEcCtD
Dihydroergotamine—Palpitations—Rivastigmine—Alzheimer's disease	0.000322	0.00162	CcSEcCtD
Dihydroergotamine—CYP3A4—central nervous system—Alzheimer's disease	0.000322	0.00616	CbGeAlD
Dihydroergotamine—Hypertension—Memantine—Alzheimer's disease	0.000322	0.00162	CcSEcCtD
Dihydroergotamine—Anorexia—Donepezil—Alzheimer's disease	0.000319	0.0016	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000318	0.0016	CcSEcCtD
Dihydroergotamine—Arthralgia—Memantine—Alzheimer's disease	0.000317	0.00159	CcSEcCtD
Dihydroergotamine—Myalgia—Memantine—Alzheimer's disease	0.000317	0.00159	CcSEcCtD
Dihydroergotamine—Anxiety—Memantine—Alzheimer's disease	0.000316	0.00159	CcSEcCtD
Dihydroergotamine—Hypertension—Rivastigmine—Alzheimer's disease	0.000315	0.00158	CcSEcCtD
Dihydroergotamine—Discomfort—Memantine—Alzheimer's disease	0.000313	0.00158	CcSEcCtD
Dihydroergotamine—Hypotension—Donepezil—Alzheimer's disease	0.000313	0.00157	CcSEcCtD
Dihydroergotamine—Myalgia—Rivastigmine—Alzheimer's disease	0.00031	0.00156	CcSEcCtD
Dihydroergotamine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00031	0.00156	CcSEcCtD
Dihydroergotamine—Dry mouth—Memantine—Alzheimer's disease	0.00031	0.00156	CcSEcCtD
Dihydroergotamine—Asthenia—Galantamine—Alzheimer's disease	0.00031	0.00156	CcSEcCtD
Dihydroergotamine—Anxiety—Rivastigmine—Alzheimer's disease	0.000309	0.00155	CcSEcCtD
Dihydroergotamine—Confusional state—Memantine—Alzheimer's disease	0.000307	0.00154	CcSEcCtD
Dihydroergotamine—Discomfort—Rivastigmine—Alzheimer's disease	0.000307	0.00154	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000305	0.00153	CcSEcCtD
Dihydroergotamine—Oedema—Memantine—Alzheimer's disease	0.000304	0.00153	CcSEcCtD
Dihydroergotamine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000304	0.00153	CcSEcCtD
Dihydroergotamine—Insomnia—Donepezil—Alzheimer's disease	0.000303	0.00152	CcSEcCtD
Dihydroergotamine—Paraesthesia—Donepezil—Alzheimer's disease	0.000301	0.00151	CcSEcCtD
Dihydroergotamine—Confusional state—Rivastigmine—Alzheimer's disease	0.0003	0.00151	CcSEcCtD
Dihydroergotamine—Shock—Memantine—Alzheimer's disease	0.000299	0.0015	CcSEcCtD
Dihydroergotamine—Dyspnoea—Donepezil—Alzheimer's disease	0.000299	0.0015	CcSEcCtD
Dihydroergotamine—Somnolence—Donepezil—Alzheimer's disease	0.000298	0.0015	CcSEcCtD
Dihydroergotamine—Oedema—Rivastigmine—Alzheimer's disease	0.000297	0.0015	CcSEcCtD
Dihydroergotamine—Tachycardia—Memantine—Alzheimer's disease	0.000297	0.00149	CcSEcCtD
Dihydroergotamine—Diarrhoea—Galantamine—Alzheimer's disease	0.000296	0.00149	CcSEcCtD
Dihydroergotamine—Dyspepsia—Donepezil—Alzheimer's disease	0.000295	0.00148	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000294	0.00148	CcSEcCtD
Dihydroergotamine—Shock—Rivastigmine—Alzheimer's disease	0.000293	0.00147	CcSEcCtD
Dihydroergotamine—Decreased appetite—Donepezil—Alzheimer's disease	0.000291	0.00146	CcSEcCtD
Dihydroergotamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00029	0.00146	CcSEcCtD
Dihydroergotamine—Anorexia—Memantine—Alzheimer's disease	0.00029	0.00146	CcSEcCtD
Dihydroergotamine—Fatigue—Donepezil—Alzheimer's disease	0.000289	0.00145	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000288	0.00145	CcSEcCtD
Dihydroergotamine—Pain—Donepezil—Alzheimer's disease	0.000286	0.00144	CcSEcCtD
Dihydroergotamine—Dizziness—Galantamine—Alzheimer's disease	0.000286	0.00144	CcSEcCtD
Dihydroergotamine—Hypotension—Memantine—Alzheimer's disease	0.000284	0.00143	CcSEcCtD
Dihydroergotamine—Anorexia—Rivastigmine—Alzheimer's disease	0.000284	0.00143	CcSEcCtD
Dihydroergotamine—Hypotension—Rivastigmine—Alzheimer's disease	0.000278	0.0014	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000277	0.00139	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000276	0.00139	CcSEcCtD
Dihydroergotamine—Insomnia—Memantine—Alzheimer's disease	0.000275	0.00138	CcSEcCtD
Dihydroergotamine—Vomiting—Galantamine—Alzheimer's disease	0.000275	0.00138	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000274	0.00138	CcSEcCtD
Dihydroergotamine—Paraesthesia—Memantine—Alzheimer's disease	0.000273	0.00137	CcSEcCtD
Dihydroergotamine—Rash—Galantamine—Alzheimer's disease	0.000272	0.00137	CcSEcCtD
Dihydroergotamine—Dermatitis—Galantamine—Alzheimer's disease	0.000272	0.00137	CcSEcCtD
Dihydroergotamine—Dyspnoea—Memantine—Alzheimer's disease	0.000271	0.00136	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000271	0.00136	CcSEcCtD
Dihydroergotamine—Headache—Galantamine—Alzheimer's disease	0.000271	0.00136	CcSEcCtD
Dihydroergotamine—Somnolence—Memantine—Alzheimer's disease	0.00027	0.00136	CcSEcCtD
Dihydroergotamine—Insomnia—Rivastigmine—Alzheimer's disease	0.000269	0.00135	CcSEcCtD
Dihydroergotamine—Dyspepsia—Memantine—Alzheimer's disease	0.000268	0.00135	CcSEcCtD
Dihydroergotamine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000267	0.00134	CcSEcCtD
Dihydroergotamine—Urticaria—Donepezil—Alzheimer's disease	0.000266	0.00134	CcSEcCtD
Dihydroergotamine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000265	0.00133	CcSEcCtD
Dihydroergotamine—Abdominal pain—Donepezil—Alzheimer's disease	0.000265	0.00133	CcSEcCtD
Dihydroergotamine—Body temperature increased—Donepezil—Alzheimer's disease	0.000265	0.00133	CcSEcCtD
Dihydroergotamine—Somnolence—Rivastigmine—Alzheimer's disease	0.000264	0.00133	CcSEcCtD
Dihydroergotamine—Decreased appetite—Memantine—Alzheimer's disease	0.000264	0.00133	CcSEcCtD
Dihydroergotamine—Fatigue—Memantine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Dihydroergotamine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Dihydroergotamine—Pain—Memantine—Alzheimer's disease	0.00026	0.00131	CcSEcCtD
Dihydroergotamine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000259	0.0013	CcSEcCtD
Dihydroergotamine—Nausea—Galantamine—Alzheimer's disease	0.000257	0.00129	CcSEcCtD
Dihydroergotamine—Fatigue—Rivastigmine—Alzheimer's disease	0.000256	0.00129	CcSEcCtD
Dihydroergotamine—Pain—Rivastigmine—Alzheimer's disease	0.000254	0.00128	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Memantine—Alzheimer's disease	0.000251	0.00126	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000249	0.00125	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000247	0.00124	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000245	0.00123	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000243	0.00122	CcSEcCtD
Dihydroergotamine—Urticaria—Memantine—Alzheimer's disease	0.000242	0.00121	CcSEcCtD
Dihydroergotamine—Body temperature increased—Memantine—Alzheimer's disease	0.00024	0.00121	CcSEcCtD
Dihydroergotamine—Abdominal pain—Memantine—Alzheimer's disease	0.00024	0.00121	CcSEcCtD
Dihydroergotamine—Asthenia—Donepezil—Alzheimer's disease	0.00024	0.00121	CcSEcCtD
Dihydroergotamine—Pruritus—Donepezil—Alzheimer's disease	0.000237	0.00119	CcSEcCtD
Dihydroergotamine—ABCB1—nervous system—Alzheimer's disease	0.000237	0.00453	CbGeAlD
Dihydroergotamine—Urticaria—Rivastigmine—Alzheimer's disease	0.000236	0.00119	CcSEcCtD
Dihydroergotamine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000235	0.00118	CcSEcCtD
Dihydroergotamine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000235	0.00118	CcSEcCtD
Dihydroergotamine—Diarrhoea—Donepezil—Alzheimer's disease	0.000229	0.00115	CcSEcCtD
Dihydroergotamine—ABCB1—central nervous system—Alzheimer's disease	0.000228	0.00436	CbGeAlD
Dihydroergotamine—Hypersensitivity—Memantine—Alzheimer's disease	0.000224	0.00113	CcSEcCtD
Dihydroergotamine—ABCB1—cerebellum—Alzheimer's disease	0.000223	0.00426	CbGeAlD
Dihydroergotamine—Dizziness—Donepezil—Alzheimer's disease	0.000221	0.00111	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000219	0.0011	CcSEcCtD
Dihydroergotamine—Asthenia—Memantine—Alzheimer's disease	0.000218	0.0011	CcSEcCtD
Dihydroergotamine—Pruritus—Memantine—Alzheimer's disease	0.000215	0.00108	CcSEcCtD
Dihydroergotamine—Asthenia—Rivastigmine—Alzheimer's disease	0.000213	0.00107	CcSEcCtD
Dihydroergotamine—Vomiting—Donepezil—Alzheimer's disease	0.000213	0.00107	CcSEcCtD
Dihydroergotamine—Rash—Donepezil—Alzheimer's disease	0.000211	0.00106	CcSEcCtD
Dihydroergotamine—Dermatitis—Donepezil—Alzheimer's disease	0.000211	0.00106	CcSEcCtD
Dihydroergotamine—Pruritus—Rivastigmine—Alzheimer's disease	0.00021	0.00106	CcSEcCtD
Dihydroergotamine—Headache—Donepezil—Alzheimer's disease	0.00021	0.00105	CcSEcCtD
Dihydroergotamine—Diarrhoea—Memantine—Alzheimer's disease	0.000208	0.00105	CcSEcCtD
Dihydroergotamine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000204	0.00102	CcSEcCtD
Dihydroergotamine—Dizziness—Memantine—Alzheimer's disease	0.000201	0.00101	CcSEcCtD
Dihydroergotamine—Nausea—Donepezil—Alzheimer's disease	0.000199	0.001	CcSEcCtD
Dihydroergotamine—Dizziness—Rivastigmine—Alzheimer's disease	0.000197	0.000989	CcSEcCtD
Dihydroergotamine—Vomiting—Memantine—Alzheimer's disease	0.000193	0.000972	CcSEcCtD
Dihydroergotamine—Rash—Memantine—Alzheimer's disease	0.000192	0.000964	CcSEcCtD
Dihydroergotamine—Dermatitis—Memantine—Alzheimer's disease	0.000192	0.000963	CcSEcCtD
Dihydroergotamine—Headache—Memantine—Alzheimer's disease	0.000191	0.000958	CcSEcCtD
Dihydroergotamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000189	0.000951	CcSEcCtD
Dihydroergotamine—Rash—Rivastigmine—Alzheimer's disease	0.000188	0.000943	CcSEcCtD
Dihydroergotamine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000187	0.000942	CcSEcCtD
Dihydroergotamine—Headache—Rivastigmine—Alzheimer's disease	0.000186	0.000937	CcSEcCtD
Dihydroergotamine—ABCB1—brain—Alzheimer's disease	0.000181	0.00346	CbGeAlD
Dihydroergotamine—Nausea—Memantine—Alzheimer's disease	0.000181	0.000908	CcSEcCtD
Dihydroergotamine—Nausea—Rivastigmine—Alzheimer's disease	0.000177	0.000888	CcSEcCtD
Dihydroergotamine—HTR2B—Signaling Pathways—MEF2C—Alzheimer's disease	1.16e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.15e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2A—Alzheimer's disease	1.15e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCR5—Alzheimer's disease	1.14e-05	0.000195	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2A—Alzheimer's disease	1.14e-05	0.000195	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.14e-05	0.000194	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PRKCG—Alzheimer's disease	1.13e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.13e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	1.13e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—A2M—Alzheimer's disease	1.13e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.13e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.13e-05	0.000192	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2A—Alzheimer's disease	1.12e-05	0.000191	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	1.11e-05	0.00019	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.11e-05	0.000189	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NGF—Alzheimer's disease	1.11e-05	0.000188	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	1.1e-05	0.000187	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	1.09e-05	0.000186	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CALM1—Alzheimer's disease	1.08e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCR5—Alzheimer's disease	1.08e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	1.07e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—APOE—Alzheimer's disease	1.07e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—LEP—Alzheimer's disease	1.07e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CALM1—Alzheimer's disease	1.07e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—LEP—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—APOE—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CAV1—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.06e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.05e-05	0.00018	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CAV1—Alzheimer's disease	1.05e-05	0.00018	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.05e-05	0.000179	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CALM1—Alzheimer's disease	1.05e-05	0.000178	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—APOE—Alzheimer's disease	1.04e-05	0.000178	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—LEP—Alzheimer's disease	1.04e-05	0.000178	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	1.04e-05	0.000177	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CAV1—Alzheimer's disease	1.03e-05	0.000176	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ESR1—Alzheimer's disease	1.02e-05	0.000174	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	1.02e-05	0.000174	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ESR1—Alzheimer's disease	1.02e-05	0.000173	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—F2—Alzheimer's disease	1.01e-05	0.000172	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—F2—Alzheimer's disease	1e-05	0.000171	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	9.95e-06	0.00017	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ESR1—Alzheimer's disease	9.94e-06	0.000169	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	9.93e-06	0.000169	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NOTCH1—Alzheimer's disease	9.89e-06	0.000169	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	9.87e-06	0.000168	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ACHE—Alzheimer's disease	9.84e-06	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—F2—Alzheimer's disease	9.82e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CALM1—Alzheimer's disease	9.82e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	9.81e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—APOE—Alzheimer's disease	9.78e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—LEP—Alzheimer's disease	9.78e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	9.78e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	9.77e-06	0.000167	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	9.73e-06	0.000166	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	9.73e-06	0.000166	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CAV1—Alzheimer's disease	9.69e-06	0.000165	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.61e-06	0.000164	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	9.55e-06	0.000163	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	9.46e-06	0.000161	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	9.38e-06	0.00016	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ESR1—Alzheimer's disease	9.34e-06	0.000159	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—GSK3B—Alzheimer's disease	9.28e-06	0.000158	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—F2—Alzheimer's disease	9.23e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ENO1—Alzheimer's disease	9.22e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	9.22e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	9.21e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CREB1—Alzheimer's disease	9.21e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	9.2e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—INS—Alzheimer's disease	9.16e-06	0.000156	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	9.14e-06	0.000156	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	9.12e-06	0.000156	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	9.11e-06	0.000155	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—INS—Alzheimer's disease	9.09e-06	0.000155	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	9.07e-06	0.000155	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	9.04e-06	0.000154	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.03e-06	0.000154	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	9.02e-06	0.000154	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCL2—Alzheimer's disease	9.01e-06	0.000154	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	8.96e-06	0.000153	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	8.95e-06	0.000152	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	8.94e-06	0.000152	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	8.91e-06	0.000152	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—INS—Alzheimer's disease	8.9e-06	0.000152	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—LPL—Alzheimer's disease	8.9e-06	0.000152	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	8.87e-06	0.000151	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IGF1—Alzheimer's disease	8.86e-06	0.000151	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	8.79e-06	0.00015	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	8.75e-06	0.000149	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	8.72e-06	0.000149	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	8.61e-06	0.000147	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—BCHE—Alzheimer's disease	8.57e-06	0.000146	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	8.53e-06	0.000145	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	8.47e-06	0.000144	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	8.43e-06	0.000144	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	8.4e-06	0.000143	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—INS—Alzheimer's disease	8.36e-06	0.000142	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	8.22e-06	0.00014	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	8.09e-06	0.000138	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	8.08e-06	0.000138	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NOS3—Alzheimer's disease	8.03e-06	0.000137	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	8.02e-06	0.000137	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	8.01e-06	0.000137	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	7.97e-06	0.000136	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	7.96e-06	0.000136	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	7.93e-06	0.000135	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	7.93e-06	0.000135	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	7.86e-06	0.000134	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	7.84e-06	0.000134	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.82e-06	0.000133	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.82e-06	0.000133	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	7.8e-06	0.000133	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	7.76e-06	0.000132	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	7.57e-06	0.000129	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	7.5e-06	0.000128	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.49e-06	0.000128	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	7.48e-06	0.000128	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—F2—Alzheimer's disease	7.48e-06	0.000128	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—APOE—Alzheimer's disease	7.46e-06	0.000127	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	7.44e-06	0.000127	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	7.39e-06	0.000126	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	7.37e-06	0.000126	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	7.33e-06	0.000125	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.32e-06	0.000125	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	7.23e-06	0.000123	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.21e-06	0.000123	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	7.05e-06	0.00012	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.97e-06	0.000119	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—AKT1—Alzheimer's disease	6.88e-06	0.000117	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	6.87e-06	0.000117	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	6.85e-06	0.000117	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	6.83e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CASP3—Alzheimer's disease	6.82e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	6.81e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	6.78e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL6—Alzheimer's disease	6.77e-06	0.000115	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	6.76e-06	0.000115	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	6.76e-06	0.000115	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	6.73e-06	0.000115	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	6.72e-06	0.000115	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	6.71e-06	0.000114	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.69e-06	0.000114	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	6.67e-06	0.000114	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	6.62e-06	0.000113	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	6.58e-06	0.000112	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	6.56e-06	0.000112	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	6.49e-06	0.000111	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—INS—Alzheimer's disease	6.37e-06	0.000109	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	6.33e-06	0.000108	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.28e-06	0.000107	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	6.26e-06	0.000107	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	6.26e-06	0.000107	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	6.25e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	6.23e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	6.23e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	6.22e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	6.22e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	6.2e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	6.18e-06	0.000105	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	6.18e-06	0.000105	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—LPL—Alzheimer's disease	6.15e-06	0.000105	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	6.09e-06	0.000104	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	6.07e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.06e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.99e-06	0.000102	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	5.95e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	5.94e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	5.88e-06	0.0001	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	5.78e-06	9.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.75e-06	9.81e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	5.74e-06	9.78e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	5.72e-06	9.75e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	5.7e-06	9.72e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.68e-06	9.68e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.68e-06	9.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	5.62e-06	9.58e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	5.59e-06	9.52e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.57e-06	9.5e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	5.54e-06	9.44e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	5.4e-06	9.2e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	5.36e-06	9.13e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	5.33e-06	9.08e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	5.31e-06	9.05e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.28e-06	9e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	5.28e-06	9e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	5.27e-06	8.98e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	5.24e-06	8.93e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CALM1—Alzheimer's disease	5.17e-06	8.82e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	5.16e-06	8.79e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—APOE—Alzheimer's disease	5.16e-06	8.79e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	5.15e-06	8.78e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	5.11e-06	8.71e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CAV1—Alzheimer's disease	5.11e-06	8.71e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.09e-06	8.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	5.05e-06	8.6e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	5.01e-06	8.54e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.98e-06	8.49e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	4.85e-06	8.26e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.83e-06	8.23e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.67e-06	7.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.64e-06	7.9e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.62e-06	7.88e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARG—Alzheimer's disease	4.49e-06	7.66e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—INS—Alzheimer's disease	4.4e-06	7.51e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	4.37e-06	7.45e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	4.34e-06	7.39e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.28e-06	7.3e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	4.25e-06	7.24e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.16e-06	7.1e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.14e-06	7.06e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	4e-06	6.82e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	4e-06	6.82e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	3.99e-06	6.8e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	3.97e-06	6.77e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.97e-06	6.76e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.94e-06	6.72e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.93e-06	6.7e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	3.89e-06	6.63e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.86e-06	6.58e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.79e-06	6.46e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	3.69e-06	6.29e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	3.66e-06	6.24e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	3.65e-06	6.22e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.64e-06	6.21e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.63e-06	6.2e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	3.59e-06	6.11e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.53e-06	6.02e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.41e-06	5.82e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	3.37e-06	5.74e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.37e-06	5.74e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	3.24e-06	5.51e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.19e-06	5.43e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.18e-06	5.42e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.15e-06	5.37e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	3.09e-06	5.26e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	2.96e-06	5.05e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.77e-06	4.72e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	2.73e-06	4.66e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.71e-06	4.63e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	2.57e-06	4.38e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	2.54e-06	4.33e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.38e-06	4.06e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	2.33e-06	3.97e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.18e-06	3.71e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	2.15e-06	3.66e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.78e-06	3.03e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.09e-06	1.86e-05	CbGpPWpGaD
